1. Home
  2. CSBR vs SNCR Comparison

CSBR vs SNCR Comparison

Compare CSBR & SNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • SNCR
  • Stock Information
  • Founded
  • CSBR 1985
  • SNCR 2000
  • Country
  • CSBR United States
  • SNCR United States
  • Employees
  • CSBR N/A
  • SNCR N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • SNCR EDP Services
  • Sector
  • CSBR Health Care
  • SNCR Technology
  • Exchange
  • CSBR Nasdaq
  • SNCR Nasdaq
  • Market Cap
  • CSBR 113.0M
  • SNCR 101.2M
  • IPO Year
  • CSBR 1986
  • SNCR 2006
  • Fundamental
  • Price
  • CSBR $6.21
  • SNCR $8.17
  • Analyst Decision
  • CSBR Strong Buy
  • SNCR Strong Buy
  • Analyst Count
  • CSBR 1
  • SNCR 1
  • Target Price
  • CSBR $12.00
  • SNCR $13.00
  • AVG Volume (30 Days)
  • CSBR 42.0K
  • SNCR 88.2K
  • Earning Date
  • CSBR 03-11-2025
  • SNCR 05-06-2025
  • Dividend Yield
  • CSBR N/A
  • SNCR N/A
  • EPS Growth
  • CSBR N/A
  • SNCR N/A
  • EPS
  • CSBR 0.46
  • SNCR N/A
  • Revenue
  • CSBR $58,591,000.00
  • SNCR $172,842,000.00
  • Revenue This Year
  • CSBR $15.11
  • SNCR $2.59
  • Revenue Next Year
  • CSBR $7.80
  • SNCR $4.91
  • P/E Ratio
  • CSBR $12.94
  • SNCR N/A
  • Revenue Growth
  • CSBR 19.03
  • SNCR 4.64
  • 52 Week Low
  • CSBR $3.60
  • SNCR $7.13
  • 52 Week High
  • CSBR $11.99
  • SNCR $15.46
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 36.72
  • SNCR 35.91
  • Support Level
  • CSBR $5.65
  • SNCR $7.69
  • Resistance Level
  • CSBR $8.27
  • SNCR $11.13
  • Average True Range (ATR)
  • CSBR 0.57
  • SNCR 0.78
  • MACD
  • CSBR -0.08
  • SNCR -0.28
  • Stochastic Oscillator
  • CSBR 21.67
  • SNCR 12.90

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About SNCR Synchronoss Technologies Inc.

Synchronoss Technologies Inc is a leading provider of white-label cloud, messaging, digital and network management solutions that enable its customers to keep subscribers, systems, networks and content in sync. The Synchronoss Personal CloudTM solution is designed to create an engaging and trusted customer experience through ongoing content management and engagement. The Synchronoss Personal CloudTM platform is a secure and highly scalable, white-label platform that allows its customers' subscribers to backup and protect, engage with, and manage their personal content. The company derives revenue from subscriptions and transaction-based fees. A majority of the firm's revenue is generated in the United States, and the rest is from countries across the world.

Share on Social Networks: